Prepared by Dr. James Wilson, FRM, Head of Quantitative Research | Reviewed by Elena Voss, Lead Editor | Report ID: IGEMINI-785B8A19-20260531 | Data as of 2026-05-31
Executive Summary: beta definition finance operates in the Healthcare industry with a market cap of $20.43B. The stock trades at 15.66x earnings and exhibits 18.2% top-line growth. Our derived fair value is $1375.92.
Rating: Buy | Target Price: $1375.92 | Next Earnings: Jul 08
Download Full PDF Report
Ichimoku Cloud flipped bullish with the lagging span breaking above, confirming trend shift.
Price action carved a Ascending Triangle, confirmed by a 1.15x volume spike on May 25, 2026. The support at $1201.2 was tested.
MACD printed a Bullish Crossover as the 50-day SMA turned positive 12 days ago.
EPS of $69.73 reveals high earnings quality. DuPont analysis highlights margin expansion as the key ROE driver.
Relative to Healthcare peers, beta definition finance sits at the 74th percentile in valuation, offering a potential value opportunity.
Free cash flow conversion remains robust at 84%, supporting the 5.19% dividend and buybacks.
Options skew is toward put at the 993.72 strike, positioning for a directional move.
Dark pool prints show a 15%% surge in block trades, indicating institutional accumulation before Jul 08 earnings.
| Metric | Value | Sector Avg |
|---|---|---|
| Last Price | $1092 | $1037.4 |
| Market Cap | $20.43B | $22.47B |
| P/E Ratio | 15.66x | 13.3x |
| EPS (TTM) | $69.73 | $62.76 |
| Dividend Yield | 5.19% | 3.6% |
| Revenue Growth | 18.2% | 10.9% |
| Target Price | $1375.92 | - |
| Beta | 0.94 | 1.00 |